Morning Briefing
Summaries of health policy coverage from major news organizations
Follow-Up Study Of HIV Vaccine Trial Provides Clues For Continued Research
"After two years of analyzing the results of the largest AIDS vaccine clinical trial ever held -- called RV144 -- researchers say they have found two ways the immune system can respond, which could predict whether those inoculated will be protected or are more likely to become infected with HIV," CNN's health blog "The Chart" reports. The results were presented at the AIDS Vaccine 2011 conference being held this week in Bangkok, Thailand (Young, 9/13).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
